Cardinal Health, Inc. $CAH Shares Bought by USS Investment Management Ltd

USS Investment Management Ltd boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,855 shares of the company’s stock after buying an additional 3,387 shares during the period. USS Investment Management Ltd’s holdings in Cardinal Health were worth $8,602,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in CAH. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $25,000. Bank of Jackson Hole Trust acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $27,000. Palladiem LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $28,000. Elyxium Wealth LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $34,000. Finally, Motiv8 Investments LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $38,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock opened at $226.52 on Tuesday. The business’s fifty day moving average price is $203.46 and its 200 day moving average price is $208.92. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The firm has a market capitalization of $53.05 billion, a PE ratio of 34.64, a P/E/G ratio of 1.22 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the company posted $2.35 earnings per share. Cardinal Health’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. Evercore dropped their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Citigroup dropped their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Barclays boosted their target price on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Finally, Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.